Paul Moore
Overview
Explore the profile of Paul Moore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jeong K, Zhou J, Griffin S, Jacobs E, Dearmon-Moore D, Zhai J, et al.
J Occup Environ Med
. 2018 Feb;
60(5):469-474.
PMID: 29465512
Objectives: Firefighters have elevated cancer incidence and mortality rates. MicroRNAs play prominent roles in carcinogenesis, but have not been previously evaluated in firefighters. Methods: Blood from 52 incumbent and 45...
12.
Stone Jr C, Qiu Y, Kurland I, Slaughter J, Moore P, Cook-Mills J, et al.
J Pediatr
. 2018 Feb;
197:280-285.e3.
PMID: 29398053
We examined the effect of maternal smoking on plasma and urinary levels of vitamin E isoforms in preterm infants. Maternal smoking during pregnancy decreased infant plasma alpha- and gamma-tocopherol concentrations...
13.
Sung J, Pickeral J, Liu L, Stanfield-Oakley S, Lam C, Garrido C, et al.
J Clin Invest
. 2015 Sep;
125(11):4077-90.
PMID: 26413868
Enhancement of HIV-specific immunity is likely required to eliminate latent HIV infection. Here, we have developed an immunotherapeutic modality aimed to improve T cell-mediated clearance of HIV-1-infected cells. Specifically, we...
14.
Beaudenon-Huibregtse S, Alexander E, Guttler R, Hershman J, Babu V, Blevins T, et al.
Thyroid
. 2014 May;
24(10):1479-87.
PMID: 24811481
Background: Molecular testing for oncogenic gene mutations and chromosomal rearrangements plays a growing role in the optimal management of thyroid nodules, yet lacks standardized testing modalities and systematic validation data....
15.
Moore P, He K, Tsai B
PLoS One
. 2013 Oct;
8(10):e75801.
PMID: 24146777
Following retrograde trafficking to the endoplasmic reticulum (ER), cholera toxin A1 (CTA1) subunit hijacks ER-associated degradation (ERAD) machinery and retro-translocates into the cytosol to induce toxicity. We previously established a...
16.
Moore P
Health Estate
. 2012 Dec;
66(10):67-9.
PMID: 23193928
Paul Moore, managing director of standby power specialist, Dieselec Thistle, explains the business-critical nature of standby power systems in a hospital setting, and the specification criteria that should be considered...
17.
Gschwend A, Yu Q, Moore P, Saski C, Chen C, Wang J, et al.
J Biomed Biotechnol
. 2011 Jul;
2011:929472.
PMID: 21765640
Papaya is a major fruit crop in the tropics and has recently evolved sex chromosomes. Towards sequencing the papaya sex chromosomes, two bacterial artificial chromosome (BAC) libraries were constructed from...
18.
Inoue T, Moore P, Tsai B
Annu Rev Microbiol
. 2011 Jun;
65:287-305.
PMID: 21682643
Many viruses and toxins disassemble to enter host cells and cause disease. These conformational changes must be orchestrated temporally and spatially during entry to avoid premature disassembly leading to nonproductive...
19.
Moore P, Bernardi K, Tsai B
Mol Biol Cell
. 2010 Feb;
21(7):1305-13.
PMID: 20130085
Cholera toxin (CT) is transported from the plasma membrane of host cells to the endoplasmic reticulum (ER) where the catalytic CTA1 subunit retro-translocates to the cytosol to induce toxicity. Our...
20.
Abdulwahab M, Boynes S, Moore P, Seifikar S, Al-Jazzaf A, Alshuraidah A, et al.
J Am Dent Assoc
. 2009 Aug;
140(8):1018-24.
PMID: 19654255
Objective: The authors conducted a randomized, double-blind clinical trial to evaluate pulpal anesthesia achieved after mandibular infiltration of five commonly marketed dental local anesthetic formulations as compared with a control...